6 Spam-Free Article(s) Found
https://www.zacks.com/stock/news/2230527/here-s-what-key-metrics-tell-us-about-biomarin-bmrn-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2230527
Feb 22, 2024 - Although the revenue and EPS for BioMarin (BMRN) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:-6904657245355948885
0
https://www.zacks.com/stock/news/2228608/merus-n-v-mrus-expected-to-beat-earnings-estimates-can-the-stock-move-higher?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2228608
Feb 20, 2024 - Merus N.V. (MRUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zc:4980682931509819301
0
https://www.zacks.com/stock/news/2227844/seeking-clues-to-biomarin-bmrn-q4-earnings-a-peek-into-wall-street-projections-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2227844
Feb 19, 2024 - Looking beyond Wall Street's top -and-bottom-line estimate forecasts for BioMarin (BMRN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.
zc:-9148264291346707974
0
https://www.zacks.com/stock/news/2217328/gsk-gears-up-for-q4-earnings-will-it-surpass-estimates?cid=CS-ZC-FT-analyst_blog|earnings_preview-2217328
Jan 29, 2024 - We expect GSK's specialty products like Arexvy, Cabenuva, Dovato, Bexsero, Trelegy Ellipta and Shingrix to drive fourth-quarter sales performance.
zc:2736014490641346597
0
https://www.zacks.com/stock/news/2215118/here-s-why-investors-may-bet-on-biomarin-bmrn-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2215118
Jan 24, 2024 - Here, we discuss some reasons why investing in BioMarin (BMRN) stock now may turn out to be a more prudent move than ever.
zc:4058698359472848859
0
https://www.zacks.com/stock/news/2212996/centene-cnc-chosen-to-serve-new-hampshire-s-medicaid-members?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2212996
Jan 19, 2024 - Centene's (CNC) subsidiary has been selected by the DHHS to serve the diversified health needs of members of New Hampshire's Medicaid program and thereby, earn more members.
zc:5961121629571381440
0